Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Hepatitis C Virus in Iran: Epidemiology of an Emerging Infection



Alavian SM1 ; Adibi P2 ; Zali MR3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Gastroenterology and Liver Disease, Baghiatallah University of Medical Sciences, Tehran, P.O. Box 14155/3651, Iran
  2. 2. Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Shaheed Beheshti University of Medical Sciences, Tehran, Iran

Source: Archives of Iranian Medicine Published:2005

Abstract

Hepatitis C infection has come to the top of virus-induced liver diseases in many parts of the world. In Iran, it seems that its prevalence in general population is less than 1%, which is much lower than in most of the regional countries. However, the infection is emerging mostly due to problem of intravenous drug abuse and needle-sharing in the country. On the other hand, an increase in number of centers providing hemodialysis and transfusion facilities for hemoglobinopathies generated new sources and susceptible populations in Iran. This article aims to summarize available data of Iran and to compare them with those of similar countries to find better preventive means.
Related Docs
View other Related Docs
1. Prevalence of Anti Hcv Infection in Patients With Beta-Thalassemia in Isfahan-Iran, International Journal of Preventive Medicine (2012)
2. Hepatitis C in Intravenous Drug Users: Seroprevalence and Risk Factors, Journal of Isfahan Medical School (2011)
3. Identification of Patients With Hepatitis C Virus Infection in Persons With Background of Intravenous Drug Use: The First Community Announcementbased Study From Iran, International Journal of Preventive Medicine (2012)
4. Hepatitis C Seroprevalence Among Intravenous Drug Users in Tehran, Journal of Research in Medical Sciences (2008)
5. Hepatitis C Screening in Intravenuos Drug Users in Golpayegan, Isfahan Through Community Announcement: Pilot Study, Journal of Isfahan Medical School (2011)
6. Positive Hepatitis C Virus Antibody in Cases With History of Intravenous Drug Abuse Via Community Announcement: A Useful Experience, Journal of Isfahan Medical School (2011)
7. Hepatitis C Among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors, International Journal of Preventive Medicine (2012)
8. Hepatitis C in Patients With Multi Blood Transfusion, Journal of Isfahan Medical School (2011)
Experts (# of related papers)
View all Related Experts
Behrooz Ataei (30)
Nazila Kassaian (25)
Other Related Docs
9. Hepatitis C Screening in Isfahan Drop in Centers: An Experience Description, Journal of Isfahan Medical School (2011)
10. Assessment of Hepatitis C Risk Factors in Center of Iran: A Case-Control Study, Journal of Research in Medical Sciences (2018)
11. Hepatitis C Virus Infection in Patients With Hemophilia in Isfahan, Iran, International Journal of Preventive Medicine (2012)
12. The Estimation of Direct Medical Costs of Treating Patients With Chronic Hepatitis B and C in Iran, International Journal of Preventive Medicine (2012)
13. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran, Hepatitis Monthly (2017)
14. Prevalence of Hepatitis B Virus Infection in Isfahan Province, International Journal of Preventive Medicine (2014)
15. Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline, Hepatitis Monthly (2016)
16. Systematic Review and Meta-Analysis on the Age-Specific Seroprevalence of Hepatitis a in Iran, Journal of Research in Medical Sciences (2014)
17. Isolation of Hepatitis C Virus in Norjizac Vials, Hepatitis Monthly (2010)
18. Hepatitis G Virus Exposure in Dialysis Patients and Blood Donors in Isfahan-Iran, International Journal of Preventive Medicine (2014)
19. Seroprevalence of Hepatitis C Infection Among Laboratory Health Care Workers in Isfahan, Iran, International Journal of Preventive Medicine (2012)
20. Hepatitis C Screening in Intravenous Drug Users Under Treatment With Methadone: An Action Reserch Study, Journal of Isfahan Medical School (2011)
21. Comparison of the Prevalence and Risk Factors of Hepatitis a in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The Caspian-Iii Study, Hepatitis Monthly (2016)
22. Liver Transplantation Status in Iran: A Multi-Center Report on the Main Transplant Indicators and Survival Rates, Archives of Iranian Medicine (2018)
23. Screening for Hepatocellular Carcinoma in Chronic Carriers of Hepatitis B and C in Markazi Province, Iran, Hepatitis Monthly (2007)
24. Hepatitis C Virus and Associated Risk Factors Among Prison Inmates With History of Drug Injection in Isfahan, Iran, International Journal of Preventive Medicine (2012)
25. Prevalence and Risk Factors for Hepatitis B and Hepatitis C Exposure in Iranian Prisoners: A National Study in 2016, Hepatitis Monthly (2019)
26. Detection of the Predominant Hepatitis C Virus Genotypes Using Linear Probe Assay for 5'Nc Region in Iran, Biotechnology (2012)
27. Surveillance System for Hepatitis C Infection: A Practical Approach, International Journal of Preventive Medicine (2012)
28. The Combination of Sofosbuvir and Daclatasvir Is Effective and Safe in Treating Patients With Hepatitis C and Severe Renal Impairment, Journal of Gastroenterology and Hepatology (Australia) (2020)
29. Prevalence of Hiv Infection and Related Risk Factors in Isfahan Drop in Centers, Pakistan Journal of Medical Sciences (2013)
30. Analysis of the Related Factors in Hepatitis C Virus Infection Among Hemophilic Patients in Isfahan, Iran, Hepatitis Monthly (2007)
31. Prevalence of Hbv and Hcv Infections and Associated Risk Factors in Addict Prisoners, Iranian Journal of Public Health (2006)
32. Hepatitis B and C Among Patients Infected With Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors, Hepatitis Monthly (2010)
33. Seroepidemiology of Hepatitis a Virus Infections in Over 6-Years Population in Isfahan–Iran: A Community-Based Study, Journal of Isfahan Medical School (2007)
34. Seroprevalence of Hepatitis a Virus in Patients With Chronic Hepatitis B or C in Isfahan Province, Iran, Journal of Isfahan Medical School (2012)
35. Hepatitis C in Correctional Centers: A Useful Experience, Journal of Isfahan Medical School (2011)
36. Occult Hepatitis B Virus (Hbv) Infection: A Global Challenge for Medicine, Clinical Laboratory (2012)
37. Hepatitis C Virus Genotype Frequency in Isfahan Province of Iran: A Descriptive Cross-Sectional Study, Virology Journal (2010)
38. Co-Infection of Human Immunodeficiency Virus, Hepatitis C and Hepatitis B Virus Among Injection Drug Users in Drop in Centers, Journal of Research in Medical Sciences (2014)
39. Correlates of Injecting Paraphernalia Sharing Among Male Drug Injectors in Kermanshah, Iran: Implications for Hcv Prevention, Journal of Substance Use (2020)
40. Hepatitis B Markers in Isfahan, Central Iran: A Population-Based Study, Hepatitis Monthly (2009)
41. Seroprevalence of Hepatitis a in Patients With Chronic Hepatitis C in Isfahan Province, International Journal of Preventive Medicine (2012)
42. Seroprevalence and Risk Factors of Hepatitis C Virus Among Juveniles in Correctional Center in Isfahan, Iran, International Journal of Preventive Medicine (2012)
43. Intravenous Drug Use and Hepatitis C Virus in Iran, Hepatitis Monthly (2012)
44. Anti-Hepatitis E Antibody in Hemodialysis Patients in Isfahan, Iran: Prevalence and Risk Factors, Hepatitis Monthly (2015)
45. Incarceration Is a Major Risk Factor for Blood-Borne Infection Among Intravenous Drug Users, Hepatitis Monthly (2011)
46. Hepatic Steatosis in Iranian Patients With Chronic Hepatitis C, Medical Principles and Practice (2008)
47. Hepatitis E Virus in Isfahan Province: A Population-Based Study, International Journal of Infectious Diseases (2009)
48. Hav in Isfahan Province: A Population-Based Study., Tropical gastroenterology : official journal of the Digestive Diseases Foundation (2008)
49. Intravenous Drug Use and Hepatitis C Virus in Iran, Hepatitis Monthly (2012)
50. Toxic Agents Responsible for Acute Poisonings Treated at Four Medical Settings in Iran During 2012-2013: A Report From Iran's National Drug and Poison Information Center, Asia Pacific Journal of Medical Toxicology (2016)